These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37402487)

  • 1. Survival of patients with recurrent uveal melanoma after treatment with radiation therapy.
    Lane AM; Hartley C; Go AK; Wu F; Gragoudas ES; Kim IK
    Br J Ophthalmol; 2024 May; 108(5):729-734. PubMed ID: 37402487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
    Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
    Kim JH; Shin SJ; Heo SJ; Choe EA; Kim CG; Jung M; Keum KC; Yoon JS; Lee SC; Shin SJ
    Cancer Res Treat; 2018 Oct; 50(4):1238-1251. PubMed ID: 29281872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage proton beam therapy in local recurrent uveal melanoma.
    Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma.
    Egger E; Schalenbourg A; Zografos L; Bercher L; Boehringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):138-47. PubMed ID: 11516863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas.
    Bellocq D; Roy P; Kodjikian L; Mathis T; Nguyen AM; Herault J; Rivoire M; Négrier S; Thariat J; Grange JD
    Melanoma Res; 2020 Jun; 30(3):272-278. PubMed ID: 30320630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
    Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
    Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
    Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy].
    Gambrelle J; Kodjikian L; Rouberol F; Donate D; Duquesne N; Jean-Louis B; Chauvel P; Gérard JP; Romestaing P; Grange JD
    J Fr Ophtalmol; 2004 Jan; 27(1):40-7. PubMed ID: 14968076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
    Bellerive C; Aziz HA; Bena J; Wilkinson A; Suh JH; Plesec T; Singh AD
    Am J Ophthalmol; 2017 May; 177():9-16. PubMed ID: 28163118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
    Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
    J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspected vitreous seeding of uveal melanoma: relevance of diagnostic vitrectomy.
    Metz CH; Bornfeld N; Metz KA; Gök M
    Br J Ophthalmol; 2016 May; 100(5):660-4. PubMed ID: 26359338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative management of suspicious melanocytic lesions of the iris.
    Oxenreiter MM; Lane AM; Jain P; Kim IK; Gragoudas ES
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1319-1324. PubMed ID: 30919077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
    Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
    Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.
    Ophthalmic Oncology Task Force
    Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.